There is a growing body of evidence that obesity is associated with reduced cerebral metabolism; however, the underlying mechanisms and the functional clinical implications of these observations remain unclear. The central goal of this project is to investigate a finding we have recently made that obesity is associated with decreased transport capacity for glucose across the blood-brain barrier. Furthermore, this association may be mediated by circulating fatty acids. This proposal uses state of the art neuroimaging technology coupled with classic human metabolic phenotyping methodologies to investigate the underlying mechanisms behind how the brain is impacted by obesity.
Aim 1 of this project will determine whether obesity is associated with changes in brain glucose transport and metabolism using 13C magnetic resonance spectroscopy scanning.
Aim 2 of this project will use a randomized controlled study design to assess whether acute elevations of circulating fatty acid levels amongst lean, healthy control subjects will lead to decreased brain glucose levels. Finally, Aim 3 of this project will use parallel studies using a rat model to investigate the underlying cellular mechanisms. Because the brain is exquisitely sensitive to circulating glucose levels, the findings from this proposed study will help clarify how diminished brain glucose transport in obesity may lead to diminished post-prandial satiety signaling and/or be a potential mechanism for the neurocognitive consequences of obesity.

Public Health Relevance

The majority of people in the US are overweight or obese and the lack of effective, long-term treatment options lends a particular urgency towards understanding the underlying physiologic mechanisms driving obesity. The purpose of these human and rodent studies are to investigate the impact of obesity and increased circulating fatty acid levels on the brain. The proposed studies in this R01 proposal will lay the foundation for future studies targeting brain glucose transport and metabolism alterations to treat and prevent the central nervous system complications of obesity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK123227-02
Application #
10102242
Study Section
Clinical and Integrative Diabetes and Obesity Study Section (CIDO)
Program Officer
Laughlin, Maren R
Project Start
2020-02-07
Project End
2025-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
2
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520